Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-121048
Filing Date
2024-11-20
Accepted
2024-11-20 16:42:56
Documents
5
Effectiveness Date
2024-11-20

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2428915d1_s8.htm S-8 80776
2 EXHIBIT 5.1 tm2428915d1_ex5-1.htm EX-5.1 7847
3 EXHIBIT 23.1 tm2428915d1_ex23-1.htm EX-23.1 2442
4 EX-FILING FEES tm2428915d1_ex-filingfees.htm EX-FILING FEES 15852
5 GRAPHIC tm2428915d1_ex5-1img001.jpg GRAPHIC 5805
  Complete submission text file 0001104659-24-121048.txt   116459
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283363 | Film No.: 241480968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)